Aminoglycoside nephrotoxicity: Modeling, simulation, and control

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 3, 2003, Pages 1010-1016

  Rougier, Florent ^a   Claude, Daniel ^b   Maurin, Michel ^c   Sedoglavic, Alexandre ^d   Ducher, Michel ^a   Corvaisier, Stéphane ^a   Jelliffe, Roger ^e   Maire, Pascal ^a,e,f  

^a HOSPICES CIVILS DE LYON   (France)

^b CNRS   (France)

^c INRETS LESCO   (France)

^d ECOLE POLYTECHNIQUE   (France)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f Hopital A Charial   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CREATININE;

ADULT; ARTICLE; CIRCADIAN RHYTHM; COMPARTMENT MODEL; CREATININE BLOOD LEVEL; DRUG ACCUMULATION; DRUG DOSE REGIMEN; ENDOCARDITIS; HUMAN; KIDNEY CELL; KIDNEY CORTEX; NEPHROTOXICITY; OTOTOXICITY; PRIORITY JOURNAL;

ADULT; ALGORITHMS; AMIKACIN; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CIRCADIAN RHYTHM; COMPUTER SIMULATION; CREATININE; FEMALE; HUMANS; KIDNEY CORTEX; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; MALE; MODELS, BIOLOGICAL; VANCOMYCIN;

EID: 0037417049     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.3.1010-1016.2003     Document Type: Article

References (29)

1. Barclay, M. L., C. M. J. Kirkpatrick, and E. J. Begg. 1999. Once-daily aminoglycoside therapy. Is it less toxic than multiple daily doses and how should it be monitored? Clin. Pharmacokinet. 36:89-98.
2. Beauchamp, D., and G. Labrecque. 2001. Aminoglycoside nephrotoxicity: do time and frequency of administration matter? Curr. Opin. Crit. Care 7:401-408.
3. Corvalsier, S., P. H. Maire, M. Y. Bouvier d'Yvoire, X. Barbaut, N. Bleyzac, and R. W. Jelliffe. 1998. Comparison between antimicrobial pharmacodynamic indices and bacterial killing as described by using the Zhi model. Antimicrob. Agents Chemother. 42:1731-1737.
4. De Broe, M. E., G. J. Paulus, G. Verpooten, F. Roels, N. Buyssens, R. Wedeen, and P. M. Tulkens. 1984. Early effects of gentamicin, tobramycin and amikacin on the human kidney. Kidney Int. 25:643-652.
5. De Broe, M. E., and G. A. Verpooten. 1991. Influence of dosage schedules on renal accumulation of amikacin and tobramycin in man. J. Antimicrob. Chemother. 27(Suppl. C):41-47.
6. Elliott, W. C., D. C. Houghton, D. N. Gilbert, J. Baines-Hunter, and W. M. Bennett. 1982. Gentamicin nephrotoxicity. I. Degree and permanence of acquired insensitivity. J. Lab. Clin. Med. 100:501-512.
7. Evan, A. P., and F. C. Luft. 1982. Gentamicin-induced glomerular injury, p. 67-78. In Néphrotoxicité, ototoxicité médicamenteuses. Editions INSERM (Institut National de la Santé et de la Recherche Médical), Paris, France.
8. Gibaldi, M., and D. Perrier. 1991. Drug and pharmaceutical sciences: pharmacokinetics, vol. 15, 2nd ed. Marcel Dekker, Inc., New York, N.Y.
9. Goldbeter, A., and D. Claude. 2002. Time-patterned drug administration: insights from a modelling approach. Chronobiol. Int. 19:157-175.
10. Guiliano, R. A., G. A. Verpooten, L. Verbist, R. P. Wedeen, and M. E. De Broe. 1986. In vivo uptake kinetics of aminoglycosides in the kidney cortex of rats. J. Pharmacol. Exp. Ther. 236:470-475.
11. Hill, A. V. 1910. The possible effects of the aggregation of hemoglobin on its dissociation curve. J. Physiol. 40:iv-vii.
12. Hurst, A. K., K. T. Iseri, M. A. Gill, J. K. Nogushi, T. M. Gilman, and R. W. Jelliffe. 1987. Comparison of four methods for predicting serum gentamicin concentrations in surgical patients with perforated or gangrenous appendicitis. Clin. Pharm. 6:234-238.
13. Jelliffe, R. W., and S. Jelliffe. 1972. A computer program for estimation of creatinine clearance from unstable serum creatinine levels. Math. Biosci. 14:17-24.
14. Koopman, M. G., G. C. Koomen, R. T. Krediet, E. A. de Moor, F. G. Hoek, and L. Arisz. 1989. Circadian rhythm of glomerular filtration rate in normal individuals. Clin. Sci. 77:105-111.
15. Kosek, J. C., R. I. Mazze, and J. Cousins. 1974. Nephrotoxicity of gentamicin. Lab. Investig. 30:48-57.
16. Maire, P. H., S. Corvaisier, F. Rougier, M. Bouvier D'Yvoire, D. Claude, X. Barbaut, G. Carret, F. Jehl, M. Ducher, and R. W. Jelliffe. 2000. Pharmacocinétique/pharmacodynamie clinique des antibiotiques, p. 715-731. In Précis de bactériologie clinique. Editions ESKA, Paris, France.
17. Maurin, M., F. Rougier, and P. Maire. 2000. Note de calcul sur les lois de Hill: aspects probabiliste déterministe et épistémologique. Internal report LTE2026. Institut National de la Recherche sur les Transports et leur Sécurité, Lyon, France.
18. Michaelis, L., and M. L. Menten. 1913. Die Kinetik der Invertinwirkung. Biochem. Z. 49:333-369.
19. Mingeot-Leclerq, M. P., and P. M. Tulkens. 1999. Aminoglycosides: nephrotoxicity. Antimicrob. Agents Chemother. 43:1003-1012.
20. Murry, K. R., P. S. McKinnon, B. Mitrzyk, and M. J. Rybak. 1999. Pharmacodynamic characterization of nephrotoxicity associated with once-daily aminoglycoside. Pharmacotherapy 19:1252-1260.
21. Rybak, M. J., B. J. Abate, S. L. Kang, M. J. Ruffing, S. A. Lerner, and G. L. Drusano. 1999. Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity. Antimicrob. Agents Chemother. 13:1549-1555.
22. Schentag, J. J. 1977. Renal clearance and tissue accumulation of gentamicin. Clin. Pharmacol. Ther. 22:364-370.
23. Schmitz, C., J. Hilpert, C. Jacobsen, C. Boensch, E. I. Christensen, F. C. Luft, and T. E. Willnow. 2002. Megalin deficiency offers protection from renal aminoglycoside accumulation. J. Biol. Chem. 277:618-622.
24. Schnermann, J., D. A. Häberle, J. M. Davis, and K. Thurau. 1992. Tubuloglomerular feedback control of renal vascular resistance, p. 1675-1705. In Renal physiology. Oxford University Press, Oxford, United Kingdom.
25. Schumitzky, A. 1991. Nonparametric EM algorithms for estimating prior distributions. Appl. Math. Comput. 45:143-157.
26. Sundin, D. P., C. Meyer, R. Dahl, A. Geerdes, R. Sandoval, and B. A. Molitoris. 1997. Cellular mechanism of aminoglycoside tolerance in long term gentamicin treatment. Am. J. Physiol. 41:C1309-C1318.
27. Tulkens, P. M. 1989. Nephrotoxicity of aminoglycosides. Toxicol. Lett. 46: 107-123.
28. Ware, J. H., and R. E. Bowden. 1977. Circadian rhythm analysis when output is collected at intervals. Biometrics 33:566-571.
29. Zhi, J., C. H. Nightingale, and R. Quintilini. 1986. A pharmacodynamic model for the activity of antibiotics against microorganisms under nonsaturable conditions. J. Pharm. Sci. 75:1063-1067.